Zhen Huang
Direktor/Vorstandsmitglied bei WALVAX BIOTECHNOLOGY CO., LTD.
Vermögen: 63 Mio $ am 30.04.2024
Aktive Positionen von Zhen Huang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Direktor/Vorstandsmitglied | 22.08.2019 | - |
| Corporate Officer/Principal | 01.01.2003 | 22.08.2019 | |
| Yuxi Walvax Biotechnology Co., Ltd. | Präsident | - | - |
Shanghai Zerun Biotechnology Co., Ltd.
 Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Zhen Huang
Statistik
International
| China | 4 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| President | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| WALVAX BIOTECHNOLOGY CO., LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Yuxi Walvax Biotechnology Co., Ltd. | |
Shanghai Zerun Biotechnology Co., Ltd.
Shanghai Zerun Biotechnology Co., Ltd. BiotechnologyHealth Technology Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China. | Health Technology |
- Börse
- Insiders
- Zhen Huang
- Erfahrung
